THE LATEST WORD

Top Industry Stories- November 16, 2009

Posted on November 16th, 2009 | by Rxmedyn | No Comments »

US Justice Dept warns pharma over foreign “bribes” (PharmTimes.com)

Merck stands by Zetia as small study favours Abbott’s Niaspan (PharmaTimes.com)

The Medicines Company CHAMPIONs benefits of cangrelor (PharmTimes.com)

FDA warns Genzyme as steel and rubber are found in products (PharmaTimes.com)

Degarelix: A New Approach For The Treatment Of Prostate Cancer (Medical News Today)

Exome Sequencing Identifies Mutation in Rare Disorder (MedPage Today)

AHA: Niacin Bests Ezetimibe as Add-On Therapy (MedPage Today)

Intelligent Assignment Of Part D LIS-Eligibles Could Raise New Challenges (The Pink Sheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

PBM Power Behind Pharmacogenomics: CVS Caremark Launching Program (The Pink Sheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

FDA warns Genzyme as steel and rubber are found in products (The Pink Sheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

Leave a Reply

You must be logged in to post a comment.